pentoxifylline has been researched along with Diabetic Retinopathy in 13 studies
Diabetic Retinopathy: Disease of the RETINA as a complication of DIABETES MELLITUS. It is characterized by the progressive microvascular complications, such as ANEURYSM, interretinal EDEMA, and intraocular PATHOLOGIC NEOVASCULARIZATION.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Pentoxifylline was administered daily at an oral dose of 400 mg tid in the diabetic patients for nine months." | 5.29 | Effects of pentoxifylline on choroidal blood flow in nonproliferative diabetic retinopathy. ( Brown, S; Charles, MA; Sadun, AA; Sebag, J; Tang, M, 1994) |
| "Our results suggest that pentoxifylline may have a protective action for diabetic retinopathy and might modulate risk factors for atherosclerosis in type 1 diabetes." | 5.17 | Pentoxifylline treatment for protecting diabetic retinopaty in children with type 1 diabetes. ( Atabek, ME; Baykara, M; Eklioglu, BS; Kurtoglu, S, 2013) |
| "Treatment with pentoxifylline resulted in a 23." | 2.67 | Pentoxifylline increases retinal capillary blood flow velocity in patients with diabetes. ( Hatchell, DL; Kelly, LW; Sinclair, SH; Sonkin, PL, 1993) |
| "A long-term trial with oral pentoxifylline ("Trental" 400) in a dosage of 1200 mg per day was carried out in 70 diabetic patients with and without vascular afflictions." | 1.27 | Diabetic retinal vascular complications and erythrocyte filtrability; results of a 2-year follow-up study with pentoxifylline. ( Ferrari, E; Solerte, SB, 1985) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (46.15) | 18.7374 |
| 1990's | 5 (38.46) | 18.2507 |
| 2000's | 1 (7.69) | 29.6817 |
| 2010's | 1 (7.69) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baykara, M | 1 |
| Atabek, ME | 1 |
| Eklioglu, BS | 1 |
| Kurtoglu, S | 1 |
| Lopes de Jesus, CC | 1 |
| Atallah, AN | 1 |
| Valente, O | 1 |
| Moça Trevisani, VF | 1 |
| Saldan, IR | 1 |
| Gol'tseva, SV | 1 |
| Pozza, G | 1 |
| Cordaro, C | 1 |
| Carandente, O | 1 |
| Margonato, A | 1 |
| Sonkin, PL | 2 |
| Kelly, LW | 1 |
| Sinclair, SH | 1 |
| Hatchell, DL | 2 |
| Ely, H | 1 |
| Sebag, J | 1 |
| Tang, M | 1 |
| Brown, S | 1 |
| Sadun, AA | 1 |
| Charles, MA | 1 |
| McCarty, MF | 1 |
| Freedman, SF | 1 |
| Needham, D | 1 |
| Rao, KM | 1 |
| Colombati, S | 1 |
| Monti, L | 1 |
| Baggiani, M | 1 |
| Filippini, F | 1 |
| Ferrari, E | 2 |
| Fioravanti, M | 1 |
| Patti, AL | 1 |
| Viola, C | 1 |
| Solerte, SB | 2 |
1 review available for pentoxifylline and Diabetic Retinopathy
| Article | Year |
|---|---|
Pentoxifylline for diabetic retinopathy.
Topics: Diabetic Retinopathy; Humans; Pentoxifylline; Vasodilator Agents | 2008 |
2 trials available for pentoxifylline and Diabetic Retinopathy
| Article | Year |
|---|---|
Pentoxifylline treatment for protecting diabetic retinopaty in children with type 1 diabetes.
Topics: Adolescent; Adult; Age of Onset; Blood Flow Velocity; Carotid Artery, Common; Child; Diabetes Mellit | 2013 |
Pentoxifylline increases retinal capillary blood flow velocity in patients with diabetes.
Topics: Administration, Oral; Blood Flow Velocity; Blood Viscosity; Capillaries; Diabetic Retinopathy; Doubl | 1993 |
10 other studies available for pentoxifylline and Diabetic Retinopathy
| Article | Year |
|---|---|
[Use of disaggregants in treating diabetic retinopathy].
Topics: Ascorbic Acid; Aspirin; Calcium Dobesilate; Diabetic Angiopathies; Diabetic Retinopathy; Dipyridamol | 1984 |
[Comparative evaluation of the efficacy of various methods in the treatment of diabetic retinopathies].
Topics: Adult; Aged; Blood Viscosity; Diabetic Retinopathy; Female; Humans; Male; Middle Aged; Pentoxifyllin | 1983 |
Study on relationship between erythrocyte filtration and other risk factors in diabetic angiopathy.
Topics: Diabetes Mellitus, Type 1; Diabetic Retinopathy; Erythrocytes; Female; Fibrinogen; Humans; Male; Pen | 1981 |
Is pentoxifylline the drug of the decade?
Topics: Clinical Trials as Topic; Diabetic Nephropathies; Diabetic Neuropathies; Diabetic Retinopathy; Human | 1994 |
Effects of pentoxifylline on choroidal blood flow in nonproliferative diabetic retinopathy.
Topics: Adult; Choroid; Diabetic Retinopathy; Female; Humans; Male; Middle Aged; Pentoxifylline; Pilot Proje | 1994 |
Nitric oxide deficiency, leukocyte activation, and resultant ischemia are crucial to the pathogenesis of diabetic retinopathy/neuropathy--preventive potential of antioxidants, essential fatty acids, chromium, ginkgolides, and pentoxifylline.
Topics: Animals; Antioxidants; Chromium; Diabetic Angiopathies; Diabetic Neuropathies; Diabetic Retinopathy; | 1998 |
Pentoxifylline modulates deformability, F-actin content, and superoxide anion production of polymorphonuclear leukocytes from diabetic cats.
Topics: Actins; Animals; Anions; Cats; Diabetic Retinopathy; Disease Models, Animal; Neutrophils; Pentoxifyl | 1992 |
[Effects of pentoxifylline on the ocular rheographic pulse in diabetic patients].
Topics: Adult; Blood Circulation; Diabetic Retinopathy; Female; Humans; Male; Microcirculation; Middle Aged; | 1989 |
Effects of long-term treatment (4 years) with pentoxifylline on haemorheological changes and vascular complications in diabetic patients.
Topics: Adult; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic Nephrop | 1987 |
Diabetic retinal vascular complications and erythrocyte filtrability; results of a 2-year follow-up study with pentoxifylline.
Topics: Adult; Aged; Blood Glucose; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Angiopath | 1985 |